TL;DR: Anticancer agent 3 (CAS 146537-05-5) is a chemical compound with molecular formula C20H25N3OS and molecular weight 355.17184 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
4-(aminomethyl)-1-[2-(diethylamino)ethylamino]thioxanthen-9-one
Also Known As: Anticancer agent 3, 4-(aminomethyl)-1-(2-diethylaminoethylamino)thioxanthen-9-one, 4-Aminomethyl-1-(2-diethylamino-ethylamino)-thioxanthen-9-one, 4-(aminomethyl)-1-[[2-(diethylamino)ethyl]amino]-thioxanthen-9-one, 4-(aminomethyl)-1-[2-(diethylamino)ethylamino]thioxanthen-9-one
| Molecular Formula | C20H25N3OS |
| Molecular Weight | 355.17184 g/mol |
| XLogP | 2.4 |
| Topological Polar Surface Area (TPSA) | 83.7 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Exact Mass | 355.17184 Da |
| Heavy Atoms | 25 |
| Complexity | 443.0 |
| SMILES | CCN(CC)CCNC1=C2C(=C(C=C1)CN)SC3=CC=CC=C3C2=O |
| InChIKey | RPGMVOVTCDJHJS-UHFFFAOYSA-N |
The XLogP value of 2.4 suggests moderate lipophilicity, balancing water solubility and membrane permeability for Anticancer agent 3. The TPSA of 83.7 Ų falls within the moderate polarity range, balancing permeability and solubility for Anticancer agent 3. Following Lipinski's Rule of Five, Anticancer agent 3 has 2 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
The CAS number of Anticancer agent 3 is 146537-05-5.
The molecular formula of Anticancer agent 3 is C20H25N3OS.
The molecular weight of Anticancer agent 3 is 355.17184 g/mol.
You can request a quote for Anticancer agent 3 directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Yes, CoreyChem provides custom synthesis services for Anticancer agent 3 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.
Request a quote for CAS 146537-05-5. Our professional technical team will respond with pricing and lead time.